Results

Total Results: 1,187 records

Showing results for "weeks".

221. Noninvasive Treatments for Low Back Pain: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_clinician.pdf
     November 01, 2016 - with persistent symptoms, continued improvement is often seen in the subacute phase between 4 and 12 weeks … In a minority of patients, nonradicular low back pain lasts longer than 12 weeks, at which point it

222. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
     April 01, 2012 - In trials, effects on pulmonary function were reported as early as 2 weeks, and a statistically significant … Six percent more BT-treated patients were hospitalized during the treatment period (up to 6 weeks after … In the posttreatment period (6 to 52 weeks after BT), the BT group experienced fewer severe exacerbations … placebo through week 24 (p <0.001). 25 Effects on pulmonary function were observed as early as 2 weeks … By 48 weeks, patients treated with ivacaftor had gained significantly more weight and secreted significantly

223. Topic Coming Back CER 28 DMARDs in Children with JIA NSD _SJ Clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_overview.pdf
     March 27, 2014 - arthritis • Psoriatic arthritis • Other (arthritis of unknown cause with symptoms lasting more than 6 weeks

224. Template for Reports Developed (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
     October 26, 2012 - Duration of followup of 2 weeks should be sufficient for initial response and 6-8 for sustained … Duration of followup of 2 weeks should be sufficient for initial response and 6-8 for sustained … Duration of follow-up would likely be short (a few weeks). … without recurrence, as late recurrences after 8 weeks are rare. … Duration of follow-up would be short (a few weeks).

225. Middle Ear Infections: What to Expect and Treatment Options (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-3rdplace_tympanic.pdf
     May 29, 2025 - Surgery may be needed to repair a perforation if it persists for more than 6 weeks (7).

226. Migraine-Prevention Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
     June 01, 2013 - to help define the Key Questions.16 The Key Questions were then posted for public comment for 4 weeks … We abstracted the time when the outcomes were assessed as weeks from randomization and time of followup … The trials lasted an average of 20 weeks (ranging from 6 to 35 weeks). … no differences in adverse effects with topiramate and sodium valproate when administered for 12 weeks … On average, the trials lasted 20 weeks.

227. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - The company also reported that the drug led to reduced body weight after 24 and 48 weeks of treatment … Patients received standard exenatide 5 mcg twice daily for 4 weeks followed by 10 mcg twice daily for … 20 weeks or exenatide extended release 2 mg once weekly. … At 24 weeks, the once- weekly group produced significantly greater changes from baseline (least squares … Patients could continue for an additional 24 weeks for a total of 48 weeks of treatment.

228. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
     March 01, 2013 - C-6 Reference Study, Sample Inclusion Criteria Exclusion Criteria Active Control Sponsorship weeks … Darifenacin (7.5 mg once daily for 2 weeks, then optional titration to 15 mg daily) Placebo Not … for OAB including electro stimulation therapy or start of a bladder training program during the 2 weeks … antimuscarinic treatment; and any nonsurgical treatment for incontinence within 4 weeks of the first … study visit; treatment within 2 weeks before randomization with any drug for incontinence (except

229. Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
     June 01, 2022 - therapy for outcomes related to pain, function, pain relief satisfaction, and quality of life up to 4 weeks … ; 2 weeks to 4 weeks? … ; 2 weeks to 4 weeks? … ; 2 weeks to 4 weeks? … ; 2 weeks to 4 weeks None Settings ED, physician’s office, hospital None Study design Original

230. Premature Babies | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/premature-babies

231. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/12_pregnancy_potential_high_impact_june_2012.pdf
     January 01, 2012 - Disease Control and Prevention indicate VLBW and extreme prematurity (infants born at fewer than 32 weeks … from a study of 183 patients whose fetus had spina bifida who either had prenatal surgery before 16 weeks … Disease Control and Prevention indicate VLBW and extreme prematurity (infants born at fewer than 32 weeks … At 37 weeks, a planned cesarean section is performed. 40 Adzick and colleagues (2011) presented … from a study of 183 patients whose fetus had spina bifida who either had prenatal surgery before 16 weeks

232. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - Index scores at every time point and more improvement in visual analog scale neck pain score at 6 weeks … the same day (for preparations that undergo only centrifugation with no additives) or up to a few weeks … after treatment, 3.2 (range 1–4)  At 24 weeks after treatment, 2.9 (range 0–4) They also reported … after treatment, 77.3 points (range 60–95)  At 24 weeks after treatment, 88.9 points (range 69–98 … more than 3 months’ duration) who were treated with three intra-articular PRP injections every 2 weeks

233. Febrile-Infants-Diagnosis-Management Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/febrile-infants-diagnosis-management_executive.pdf
     March 01, 2012 - Febrile infants less than eight weeks old. Predictors of infection. … The clinical characteristics and infectious outcomes of febrile infants aged 8 to 12 weeks. … Evaluation of fever in infants less than 8 weeks old. South Med J 1987 Aug;80(8):948-52. … Urinary tract infection in febrile infants younger than eight weeks of Age. … Urinary tract infections in febrile infants younger than 8 weeks of age.[see comment].

234. Hemorrhage-Postpartum Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hemorrhage-postpartum_executive.pdf
     April 01, 2015 - hours of birth, or secondary/delayed/ late, occurring from more than 24 hours postbirth to up to 12 weeks … The framework for management of PPH includes women with PPH from immediately postbirth to 12 weeks … postpartum following pregnancy of at least 24 weeks’ gestation. … Category Criteria Study population • KQs 1–3, 5: Women with PPH from immediately postbirth to 12 weeks … postpartum following pregnancy >24 weeks’ gestation • KQ4: Women with stabilized PPH and acute blood

235. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - the same day (for preparations that undergo only centrifugation with no additives) or up to a few weeks … Three weeks after surgery, patients were treated with intra-articular MSC and hyaluronic acid injection … under ultrasound guidance.37-40 Typically, multiple injections are given over the course of several weeks … Followup evaluation was performed at 3 weeks, 3 months, and 6 months by a blinded, independent observer … more than 3 months’ duration who were treated with three intra-articular PRP injections every 2 weeks

236. Noninvasive, Nonpharmacological Treatment for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharma-treatment-pain_research-protocol-amended.pdf
     September 20, 2017 - the Systematic Review Nature and Burden of Chronic Pain Chronic pain, defined as pain lasting 12 weeks … provided here: • Population(s): Adults with the following chronic pain (defined as pain lasting 12 weeks … • Exclusion of studies that do not have at least 4 weeks followup post intervention. … Age, sex, co-morbidities (KQ 6) KQ=Key Question *Chronic pain is defined as pain lasting ≥ 12 weeks … General Inclusion Criteria • Adults with the following chronic pain (defined as pain lasting 12 weeks

237. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
     September 18, 2012 - Online: October 22, 2012 2 Hepatitis B Birth and older Hib (Haemophilus influenzae type b) 6 weeks … months and older Influenza (live attenuated) 2 years and older IPV (inactivated polio vaccine) 6 weeks … meningococcal polysaccharide vaccine) 2 years and older PCV13 (pneumococcal conjugate vaccine) 6 weeks … – 18 years Pneumococcal polysaccharide vaccine 2 years and older Rotavirus 6 weeks – 8 months Tdap

238. Radiotherapy-Proton-Beam Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiotherapy-proton-beam_research.pdf
     May 01, 2012 - We calculated mean payment per beneficiary and treatment course (several weeks for some tumors) as the … therapy (one week), whereas other cancers, such as prostate, receive daily doses for six to eight weeks … The cost of such an expansion will be fur- ther multiplied by the fact that with 6 to 8 weeks of therapy

239. Topic 0613 Tympanostomy Tubes NSD FINAL (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0765-150129.pdf
     November 03, 2014 - or drainage which results from tube insertion, affecting approximately 16% of children within four weeks

240. Evidence Summary for CER 239: Acute Treatments for Episodic Migraine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
     December 01, 2020 - Evidence Summary for CER 239: Acute Treatments for Episodic Migraine Comparative Effectiveness Review Number 239 Acute Treatments for Episodic Migraine Evidence Summary Main Points • Compared with placebo, treatments such as triptans, NSAIDs (nonsteroidal anti- inflammatory drugs), dihydroergotamine, antieme…